Cancer cachexia impacts almost 90% of people living with pancreatic cancer. Learn more about this condition in this Q&A with Nicolas Clifford, PanCAN’s manager of research and education communication.

Effective care demands systematic screening, targeted symptom control, and coordinated exercise and nutrition strategies integrated within oncology practice. Anorexia-cachexia syndrome (ACS) in ...

The Pancreatic Cancer Action Network is holding a webinar “Nutrition and Pancreatic Cancer: Weight Loss, Enzymes and More” to talk about common nutritional challenges related to pancreatic cancer.

Vistagen Therapeutics is doubling down on its lead social anxiety candidate, even after the asset failed a phase 3 trial last December. | Vistagen Therapeutics is doubling down on its lead social ...

The metabolism–cancer axis is currently at a critical inflection point. A landmark August 2025 JAMA Oncology study reported a 17% reduction in overall ...

A new study coordinated by Dr. Salvatore Cortellino and Professor Antonio Giordano, President of the Sbarro Health Research Organization (SHRO) and molecular oncologist at Temple University and the ...

Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients, well above the standard of care benchmark from GnP of 35% overall survival; On track for expanded pancreatic cancer ...

在经典的能量调控理论中，当脂肪储备减少、瘦素水平下降时，下丘脑的NPY/AgRP饥饿信号通路会被激活，从而促进进食并恢复能量平衡。然而在癌症恶病质中，这一理论似乎并不成立。研究团队发现，即使下丘脑的饥饿信号被激活，食物摄入依然下降。

Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients, well above the standard of care benchmark from GnP of 35% overall ...

A breakthrough AI system is revolutionizing cancer immunotherapy by enabling scientists to design protein-based keys that train a patient s immune cells to attack cancer with extreme precision. This ...

Background Gut bacteria have been implicated in a wide range of health conditions, yet their potential role in preventing and treating muscle-wasting disorders remains largely unexplored. Objective We ...